703
Participants
Start Date
September 19, 2016
Primary Completion Date
October 31, 2019
Study Completion Date
October 31, 2019
Not applicable (no therapy is administered as part of this study)
"No experimental therapy or placebo is being administered in this study. All subjects in this observational study received a single intra-articular injection of SM04690 or placebo in a prior parent study."
Research Site, Birmingham
Research Site, Oro Valley
Research Site, Phoenix
Research Site, Tucson
Research Site, Canoga Park
Research Site, Carmichael
Research Site, Cerritos
Research Site, El Cajon
Research Site, Gold River
Research Site, La Mesa
Research Site, Palm Springs
Research Site, Rancho Mirage
Research Site, Sacramento
Research Site, San Diego
Research Site, San Marcos
Research Site, Spring Valley
Research Site, Boulder
Research Site, Stamford
Research Site, Trumbull
Research Site, Waterbury
Research Site, Clearwater
Research Site, Coral Gables
Research Site, DeLand
Research Site, Edgewater
Research Site, Lauderdale Lakes
Research Site, Miami
Research Site, Marietta
Research Site, Woodstock
Research Site, Chicago
Research Site, Newton
Research Site, Wichita
Research Site, Lexington
Research Site, Frederick
Research Site, Boston
Research Site, Troy
Research Site, City of Saint Peters
Research Site, Kansas City
Research Site, St Louis
Research Site, Lincoln
Research Site, Las Vegas
Research Site, Albuquerque
Research Site, Orchard Park
Research Site, Rochester
Research Site, Charlotte
Research Site, High Point
Research Site, Raleigh
Research Site, Salisbury
Research Site, Cincinnati
Research Site, Cleveland
Research Site, Duncansville
Research Site, Philadelphia
Research Site, Charleston
Research Site, Mt. Pleasant
Research Site, Rapid City
Research Site, Knoxville
Research Site, Austin
Research Site, Bedford
Research Site, Houston
Research Site, San Angelo
Research Site, Layton
Research Site, Arlington
Research Site, Charlottesville
Lead Sponsor
Biosplice Therapeutics, Inc.
INDUSTRY